Methionine inhibits cellular growth dependent on the p53 status of cells

American Journal of Surgery

Volumn 193, Issue 2, 2007, Pages 274-283

  Benavides, Maximo A ^a   Oelschlager, Denise K ^a   Zhang, Huang Ge ^a   Stockard, Cecil R ^a   Vital Reyes, Victor S ^a   Katkoori, Venkat R ^a   Manne, Upender ^a   Wang, Wenquan ^b   Bland, Kirby I ^a   Grizzle, William E ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

DU 145; Essential amino acid; LNCaP; MCF 7; p53

Indexed keywords

KI 67 ANTIGEN; METHIONINE; PROTEIN P53; SMALL INTERFERING RNA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACIDS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MALE; METHIONINE; PROSTATIC NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846190076     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.07.016     Document Type: Article

References (42)

1. Kim H.H., and Park C.S. Methionine cytotoxicity in the human breast cancer cell line MCF-7. In Vitro Cell Dev Biol Anim 39 (2003) 117-119
2. Pirollo K.F., Xu L., and Chang E.H. Non-viral gene delivery for p53. Curr Opin Mol Ther 2 (2000) 168-175
3. Sidransky D., and Hollstein M. Clinical implications of the p53 gene. Annu Rev Med 47 (1996) 285-301
4. Ruley H.E. p53 and response to chemotherapy and radiotherapy. Important Adv Oncol (1996) 37-56
5. Manne U., Weiss H.L., Myers R.B., et al. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer 83 (1998) 2456-2467
6. Anderson M.E. Glutathione: an overview of biosynthesis and modulation. Chem Biol Interact 111-112 (1998) 1-14
7. Colella S., Shen L., Baggerly K.A., et al. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. Biotechniques 35 (2003) 146-150
8. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 3 (2003) 253-266
9. Shiraishi M., Oates A.J., and Sekiya T. An overview of the analysis of DNA methylation in mammalian genomes. Biol Chem 383 (2002) 893-906
10. Thomas T., and Thomas T.J. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58 (2001) 244-258
11. Soule H.D., Vazguez J., Long A., et al. A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51 (1973) 1409-1416
12. Takahashi K., and Suzuki K. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int J Cancer 55 (1993) 453-458
13. Pratt S.E., and Pollak M.N. Estrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53 (1993) 5193-5198
14. Horoszewicz J.S., Leong S.S., Kawinski E., et al. LNCaP model of human prostatic carcinoma. Cancer Res 43 (1983) 1809-1818
15. Stone K.R., Mickey D.D., Wunderli H., et al. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21 (1978) 274-281
16. Cory A.H., Owen T.C., Barltrop J.A., et al. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3 (1991) 207-212
17. Grizzle W.E., Manne U., Jhala N.C., et al. Molecular characterization of colorectal neoplasia in translational research. Arch Pathol Lab Med 125 (2001) 91-98
18. Grizzle W.E., Myers R.B., Arnold M.M., et al. Evaluation of biomarkers in breast and prostate cancer. J Cell Biochem Suppl 19 (1994) 259-266
19. Manne U., Myers R.B., Moron C., et al. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma. Int J Cancer 74 (1997) 346-358
20. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
21. Myers R.B., Oelschlager D.K., Grizzle W.E., et al. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. J Natl Cancer Inst 86 (1994) 1140-1145
22. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76 (1979) 4350-4354
23. Hoffman R.M. Methionine dependence in cancer cells-a review. In Vitro 18 (1982) 421-428
24. Breillout F., Antoine E., and Poupon M.F. Methionine dependency of malignant tumors: a possible approach for therapy. J Natl Cancer Inst 82 (1990) 1628-1632
25. Guo H.Y., Herrera H., Groce A., et al. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res 53 (1993) 2479-2483
26. Hoffman R.M. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 738 (1984) 49-87
27. Hoffman R.M., and Erbe R.W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A 73 (1976) 1523-1527
28. Mecham J.O., Rowitch D., Wallace C.D., et al. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun 117 (1983) 429-434
29. Tisdale M., and Eridani S. Methionine requirement of normal and leukaemic haemopoietic cells in short term cultures. Leuk Res 5 (1981) 385-394
30. Wainfan E., Dizik M., Kilkenny M., et al. Prolonged survival of female AKR mice fed diets supplemented with methionine and choline. Carcinogenesis 11 (1990) 361-363
31. Finkelstein J.D., and Martin J.J. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 261 (1986) 1582-1587
32. Hawrylewicz E.J., Huang H.H., and Blair W.H. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J Nutr 121 (1991) 1693-1698
33. Riou G., Barrois M., Prost S., et al. The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol Carcinog 12 (1995) 124-131
34. Stiewe T., Zimmermann S., Frilling A., et al. Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res 62 (2002) 3598-3602
35. Yang Y., and Yu X. Regulation of apoptosis: the ubiquitous way. FASEB J 17 (2003) 790-799
36. Balint E.E., and Vousden K.H. Activation and activities of the p53 tumour suppressor protein. Br J Cancer 85 (2001) 1813-1823
37. Hollstein M., Sidransky D., Vogelstein B., et al. p53 mutations in human cancers. Science 253 (1991) 49-53
38. Wahl G.M., and Carr A.M. The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nat Cell Biol 3 (2001) E277-E286
39. Hanawalt P.C. Controlling the efficiency of excision repair. Mutat Res 485 (2001) 3-13
40. Smith M.L., and Seo Y.R. p53 regulation of DNA excision repair pathways. Mutagenesis 17 (2002) 149-156
41. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
42. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11 (2001) S27-S31